ALNY
Alnylam Pharmaceuticals, Inc. · Healthcare
CEO John Maraganore sold $6.8M of Alnylam Pharmaceuticals, Inc.
Sold$6,788,196
$199.78Price
33,979Shares
−13%Stake
What ALNY did after the filing
- The stock from Tue, Aug 17 open, $195.71
- −9.3%
- S&P 500, same days
- −1.9%
Measured over 30 trading days, to the Sep 29 close.
Traded Fri, Aug 13. Filed Mon, Aug 16, 4:38 PM ET, after the close. Returns use the Aug 17 open and the Sep 29 close. Not investment advice.